Jiaying Wu

Jiaying Wu

Auto-generated profile, based on publicly available information

Jiaying Wu

Guangxi University of Chinese Medicine, Nanning 530000, Guangxi, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2023 in Disease Markers
Verified
Journal Article
Open access
PDF file
QLQing Li
Qing Li
ZYZongjing Yang
Zongjing Yang
XLXingqing Ling
Xingqing Ling
JYJunming Ye
Junming Ye
JWJiaying Wu
Jiaying Wu
JZJinghui Zheng
Jinghui Zheng
Objective. Tumor microenvironment (TME) research can provide a crucial direction for the innovation and continuous improvement of novel biologic therapies for cancer. This study examined the relationship between the TME, expression profiles of the tumor-infiltrating immune cell, and prognostic gene expression in ovarian cancer (OC). Materials and Methods. Screening of CD3E, CD3G, CD2, CD3D, CCL19, and IL2RG was performed using the bioinformatics methods. Results. All six genes were found to participate in immune-related molecular mechanisms and could regulate the expression of tumor-infiltrating cells. A KaplanMeier survival analysis results demonstrated a strong association between overall survival and all gene expressions in patients with OC. CIBERSORT analysis results showed that the expression level of all genes was positively correlated with γδ T cell proportions. Conclusion. Therefore, in the OC microenvironment, CD3E, CD3G, CD2, CD3D, CCL19, and IL2RG can be potential immunotherapy targets and prognostic markers.